{
    "nctId": "NCT00806936",
    "officialTitle": "A 16-week Multicentre, Open Label, Non-interventional, Observational Study to Investigate the Status of Human Insulin or Insulin Analogue Treatments With Focusing on Efficacy and Safety in Type 2 Diabetes Subjects Inadequately Controlled With Two or More Oral Antidiabetic Drugs in China",
    "inclusionCriteria": "* After the investigator has taken the decision to use human insulin or insulin analogues to treat the subject, any type 2 diabetic previously inadequately controlled with two or more OADs is eligible for the study\n* The selection of the subjects will be at the discretion of the individual investigator",
    "exclusionCriteria": "* Known or suspected allergy to trial product(s) or related products\n* Subjects who are unlikely to comply with protocol requirements, e.g. uncooperative attitude, inability to return for the final visit\n* Subjects who previously enrolled in this study\n* Females of childbearing potential who are pregnant, breast-feeding or intend to become pregnant or are not using adequate contraceptive methods\n* The receipt of any investigational product within 3 months prior to this trial"
}